ArticleScientific reports2025
Theoretical studies of arbutin, glutathione, and sea cucumber extracts as inhibitors of tyrosinase.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tyrosinase is a crucial enzyme targeted for the development of various skin-whitening agents due to its role in regulating key steps in melanin production. Despite the significance of human tyrosinase (hTYR), its crystal structure remains unresolved, hindering the development of specific inhibitors. Researchers frequently use mushroom tyrosinase (mTYR) to evaluate the inhibition capabilities of compounds, but the structural differences between hTYR and mTYR present considerable challenges in accurately developing hTYR-specific inhibitors. For instance, compounds like kojic acid show promising inhibitory effects but face limitations due to cytotoxicity or allergic reactions. This study aims to utilize the AlphaFold-predicted structure of hTYR to provide insights for developing specific inhibitors by comparing it with mTYR. We utilized natural tyrosinase inhibitors reported in the literature for molecular docking and molecular dynamic simulations to examine their binding modes with mTYR and hTYR. Through the analysis of these binding interactions and dynamic behaviors, we intend to identify residues that significantly enhance affinity, assess reliable binding modes, and offer essential insights for the development of effective hTYR inhibitors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.